Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides.

[1]  W S Hancock,et al.  Analysis of Oligonucleotides by HPLC-Electrospray Ionization Mass Spectrometry. , 1997, Analytical chemistry.

[2]  R. Diasio,et al.  Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV‐infected subjects , 1995, Clinical pharmacology and therapeutics.

[3]  L. Cummins,et al.  On-line HPLC electrospray mass spectrometry of phosphorothioate oligonucleotide metabolites. , 1997, Analytical chemistry.

[4]  R. Griffey,et al.  Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer , 1997 .

[5]  S. Stavchansky,et al.  Determination of single-stranded oligodeoxynucleotides by capillary gel electrophoresis with laser induced fluorescence and on column derivatization. , 1996, Journal of chromatography. A.

[6]  P. Nicklin,et al.  Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. , 1997, Biochemical pharmacology.

[7]  Peter Natesan Pushparaj,et al.  SHORT INTEFERING RNA (siRNA) AS A NOVEL THERAPEUTIC , 2006, Clinical and Experimental Pharmacology and Physiology.

[8]  W. Guo,et al.  Quantification of raf antisense oligonucleotide (rafAON) in biological matrices by LC-MS/MS to support pharmacokinetics of a liposome-entrapped rafAON formulation. , 2005, Biomedical chromatography : BMC.

[9]  C. Bloomfield,et al.  Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Yuan-Qing Xia,et al.  LC-MS Development strategies for quantitative bioanalysis. , 2006, Current drug metabolism.

[11]  J. Gebler,et al.  Analysis of native and chemically modified oligonucleotides by tandem ion-pair reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.

[12]  J. Rozenski,et al.  Interpretation of oligonucleotide mass spectra for determination of sequence using electrospray ionization and tandem mass spectrometry. , 1996, Analytical chemistry.

[13]  J. Banoub,et al.  Recent developments in mass spectrometry for the characterization of nucleosides, nucleotides, oligonucleotides, and nucleic acids. , 2005, Chemical reviews.

[14]  S. Crooke,et al.  Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration. , 2001, Biochemical pharmacology.

[15]  R. S. Coleman,et al.  Analysis of post-synthetically modified oligodeoxynucleotides by electrospray ionization mass spectrometry. , 1994 .

[16]  K. Bleicher,et al.  Various factors influencing the signal intensity of oligonucleotides in electrospray mass spectrometry. , 1994, Biological mass spectrometry.

[17]  C. Huber,et al.  Sheath liquid effects in capillary high-performance liquid chromatography-electrospray mass spectrometry of oligonucleotides. , 2000, Journal of chromatography. A.

[18]  S. Ito,et al.  Enhanced mass detection of oligonucleotides using reverse-phase high-performance liquid chromatography/electrospray ionization ion-trap mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[19]  A. Krieg,et al.  Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration. , 2005, Biochemical pharmacology.

[20]  Demin Zhou,et al.  RNA interference and potential applications. , 2006, Current topics in medicinal chemistry.

[21]  Kim Hartsough,et al.  Liquid chromatography/electrospray mass spectrometric analysis of metabolites from an inhibitory RNA duplex. , 2005, Rapid communications in mass spectrometry : RCM.

[22]  C. Huber,et al.  Analysis of nucleic acids by capillary ion-pair reversed-phase HPLC coupled to negative-ion electrospray ionization mass spectrometry. , 1999, Analytical chemistry.

[23]  C. V. Van Peteghem,et al.  Analysis of nucleic acid constituents by on‐line capillary electrophoresis‐mass spectrometry , 2005, Electrophoresis.

[24]  L. Cummins,et al.  PHOSPHOROTHIOATE OLIGONUCLEOTIDE METABOLISM: CHARACTERIZATION OF THE “N+”-MER BY CE AND HPLC-ES/MS , 1997 .

[25]  J. Gebler,et al.  Characterization of therapeutic oligonucleotides using liquid chromatography with on-line mass spectrometry detection. , 2003, Oligonucleotides.

[26]  M. Gilar.  Analysis and purification of synthetic oligonucleotides by reversed-phase high-performance liquid chromatography with photodiode array and mass spectrometry detection. , 2001, Analytical biochemistry.

[27]  E. Nordhoff,et al.  Mass spectrometry of nucleic acids. , 1996, Mass spectrometry reviews.

[28]  Jennifer A. Lockridge,et al.  Liquid chromatography electrospray ionization mass spectrometry analysis of the ocular metabolites from a short interfering RNA duplex. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[29]  A. Bruins.  Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied Topics , 1998 .

[30]  Chow H Lee,et al.  Destroying RNA as a therapeutic approach. , 2006, Current medicinal chemistry.

[31]  A. Levin,et al.  Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys. , 2004, Journal of pharmaceutical sciences.

[32]  I. Ahmad,et al.  Mass spectrometry and enzyme-linked immunosorbent assay methods for the quantitation of liposomal antisense oligonucleotide (LE-rafAON) in human plasma. , 2004, Methods in enzymology.

[33]  R. Yu,et al.  Development of an Ion-Pair Reverse-Phase Liquid Chromatographic/Tandem Mass Spectrometry Method for the Determination of an 18-Mer Phosphorothioate Oligonucleotide in Mouse Liver Tissue , 2005, European journal of mass spectrometry.

[34]  A. Levin,et al.  Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma. , 2002, Analytical biochemistry.

[35]  Herbert Oberacher,et al.  Effect of instrument tuning on the detectabilityof biopolymers in electrospray ionization mass spectrometry. , 2003, Journal of mass spectrometry : JMS.

[36]  Claes Wahlestedt,et al.  RNA Interference with chemically modified siRNA. , 2006, Current topics in medicinal chemistry.

[37]  E. Ezan,et al.  A competitive enzyme hybridization assay for plasma determination of phosphodiester and phosphorothioate antisense oligonucleotides. , 1997, Nucleic acids research.

[38]  M. Colgrave,et al.  Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins. , 2001, Mass spectrometry reviews.

[39]  P. Iversen,et al.  Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats. , 2002, Journal of pharmaceutical sciences.

[40]  G. Marcucci,et al.  Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[41]  G. Siuzdak,et al.  Liquid chromatography mass spectrometry of antisense oligonucleotides , 1995 .

[42]  G. Hardee,et al.  Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[43]  C. Huber,et al.  Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry. , 2001, Mass spectrometry reviews.

[44]  T. Krugh,et al.  Large-scale purification of synthetic oligonucleotides and carcinogen-modified oligodeoxynucleotides on a reverse-phase polystyrene (PRP-1) column. , 1990, Analytical biochemistry.

[45]  M. Graham,et al.  Metabolism of antisense oligonucleotides in rat liver homogenates. , 2000, The Journal of pharmacology and experimental therapeutics.

[46]  R. Griffey,et al.  Utility of organic bases for improved electrospray mass spectrometry of oligonucleotides. , 1995, Rapid communications in mass spectrometry : RCM.

[47]  A. Levin,et al.  Application of novel quantitative bioanalytical methods for pharmacokinetic and pharmacokinetic/pharmacodynamic assessments of antisense oligonucleotides. , 2004, Current opinion in drug discovery & development.

[48]  M. Graham,et al.  Quantitation of phosphorothioate oligonucleotides in human plasma. , 1996, Analytical biochemistry.